The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fruquintinib with PD-1 inhibitors versus TAS-102 with bevacizumab in late-line mCRC: A retrospective cohort study based on propensity score matching.
 
Rongrong Li
No Relationships to Disclose
 
Xiao-Lin Yang
No Relationships to Disclose
 
Zhen-yang Liu
No Relationships to Disclose
 
Hui-Jun Zhou
No Relationships to Disclose
 
Xian-Li Yin
No Relationships to Disclose
 
De-Yu Zeng
No Relationships to Disclose
 
Hua Shen
No Relationships to Disclose
 
Yi-Dong Zeng
No Relationships to Disclose
 
Fang Xiang
No Relationships to Disclose
 
Ke Li
No Relationships to Disclose
 
Shao-Feng Jiang
No Relationships to Disclose
 
Wu Liu
No Relationships to Disclose